The Patent Finder
MF

Musc Foundation for Research Development

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

105 patents currently held

8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3 more records may belong here and await a decision; they are not counted.

The next term ends in Jun 2027. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
15
Ending by 2030
Jun 2027
Next term end
77
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 3 fees due Jan 4 to 14, 2027 · next Jan 4
  • 5 fees due Feb 6 to 27, 2027 · next Feb 6
  • 4 fees due Apr 1 to 22, 2027 · next Apr 1
  • 3 fees due May 7 to 21, 2027 · next May 7
  • 2 fees due Jun 5 to 10, 2027 · next Jun 5
  • 1 fee due Jul 30, 2027
    The maintenance fee for CD38-NAD+ Regulated Metabolic Axis in Anti-Tumor Immunotherapy (US 11,883,430) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
  • 2 fees due Aug 16 to 27, 2027 · next Aug 16
  • 3 fees due Sep 5 to 26, 2027 · next Sep 5
  • 1 fee due Oct 23, 2027
    The maintenance fee for Activated CD26-HIGH Immune Cells and CD26-Negative Immune Cells and Uses Thereof (US 11,963,980) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
  • 1 fee due Nov 7, 2027
    The maintenance fee for T Regulatory (Treg) Cell Transplantation in Osteogenesis Imperfecta (OI) (US 11,975,024) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 5 of the patents on this record were granted since Aug 20, 2026
  • 9 terms have ended since Aug 20, 2026

What they patent

The 5 largest of its 77 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 7,759,304Targeting Complement Factor H for Treatment of Diseases
In force
 · High confidence
In forceHigh confidence
US 9,212,212Targeting Complement Factor H for Treatment of Diseases
In force
 · Medium confidence
In forceMedium confidence
US 8,735,365Targeting PAX2 for the Induction of DEFB1-MEDIATED Tumor Immunity and Cancer Therapy
In force
 · Medium confidence
In forceMedium confidence
US 8,623,617Detecting PAX2 for the Diagnosis of Breast Cancer
In force (reinstated)
 · Medium confidence
In force (reinstated)Medium confidence
US 8,722,367Detecting PAX2 for the Diagnosis of Breast Cancer
In force
 · Medium confidence
In forceMedium confidence
US 8,241,905Self-Assembling Cell Aggregates and Methods of Making Engineered Tissue Using the Same
In force
 · High confidence
In forceHigh confidence
US 8,088,603Compositions and Methods for Diagnosing, Treating, and Preventing Prostate Conditions
In force
 · High confidence
In forceHigh confidence
US 8,569,225Targeting Complement Factor H for Treatment of Diseases
In force
 · Medium confidence
In forceMedium confidence
US 8,506,499Predicting Atrial Fibrillation Recurrence by Protease and Protease Inhibitor Profiling
In force
 · High confidence
In forceHigh confidence
US 8,489,186Devices and Methods for Treatment of Myocardial Conditions
In force
 · High confidence
In forceHigh confidence
10 of 105 patents shown.
Pro members see all 105.
Pro members: see all 105 patents
Also on record, not counted in the 105: 8 patents in force now held by others · 83 patents ended · 54 applications pending · 122 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited